Novo Nordisk A/S (NVO) — Technical state

As of 2026-11-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

Closelooknet score: 55 out of 100 (momentum 28 · quality 86 · valuation 72), as of 2026-11-11.
Signal: +2.7% at the close — Holding 33.1% off its 52-week high. (as of 2026-11-09)
Trend: Novo Nordisk A/S trades 2.2% above its 50-day and 4.3% below its 200-day moving average. (as of 2026-11-09)
Index seat: HALO Growth 100

Novo Nordisk researches, manufactures and distributes pharmaceutical products through two units: Obesity and Diabetes Care, and Rare Disease. The first covers diabetes, obesity, cardiovascular and related conditions, including GLP-1 therapies such as Wegovy alongside insulin pens and dosing apps.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the NVO overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

+2.7% at the close

Holding 33.1% off its 52-week high.

The moving-average stack

vs 20-day+4.8%
vs 50-day+2.2%
vs 200-day-4.3%
52-week band33.1% off the high · +19.7% off the low
Streak2 consecutive up sessions
50-day crossprice crossed up through the 50-day 1 sessions ago
Stochastic%K 51.2 · %D 58.4

Continue: the NVO chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-09

Quick answers

What is the current Closelooknet signal on NVO?

+2.7% at the close — Holding 33.1% off its 52-week high. As of 2026-11-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is NVO above its 50-day and 200-day moving averages?

As of 2026-11-09, Novo Nordisk A/S trades +2.2% above its 50-day and -4.3% below its 200-day average, with the 20-day +4.8% away.

How far is NVO from its 52-week high?

33.1% below the 52-week high and 19.7% above the 52-week low, as of 2026-11-09.

Mentioned on Closelooknet

Where NVO appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Midterms — Dow Jumps 2.3% and Apple Hits a Record; Data-Center Power Stocks Sink Up to 15%Midday 10 · 4 Nov 2026Novo Nordisk — outlook raised, shares up 6%

Related in the Closelooknet universe

same Closelooknet index seat first, then Drug Manufacturers - General. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.